RadNet Gross Profit 2012-2026 | RDNT

RadNet gross profit from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
RadNet Annual Gross Profit
(Millions of US $)
2025 $235
2024 $249
2023 $221
2022 $166
2021 $192
2020 $106
2019 $154
2018 $108
2017 $120
2016 $109
2015 $101
2014 $115
2013 $104
2012 $104
2011 $107
RadNet Quarterly Gross Profit
(Millions of US $)
2026-03-31 $25
2025-12-31 $76
2025-09-30 $72
2025-06-30 $69
2025-03-31 $18
2024-12-31 $66
2024-09-30 $69
2024-06-30 $70
2024-03-31 $44
2023-12-31 $64
2023-09-30 $60
2023-06-30 $59
2023-03-31 $39
2022-12-31 $54
2022-09-30 $36
2022-06-30 $49
2022-03-31 $27
2021-12-31 $48
2021-09-30 $60
2021-06-30 $50
2021-03-31 $33
2020-12-31 $50
2020-09-30 $45
2020-06-30 $-4
2020-03-31 $14
2019-12-31 $45
2019-09-30 $38
2019-06-30 $43
2019-03-31 $28
2018-12-31 $24
2018-09-30 $34
2018-06-30 $34
2018-03-31 $16
2017-12-31 $35
2017-09-30 $29
2017-06-30 $31
2017-03-31 $24
2016-12-31 $33
2016-09-30 $32
2016-06-30 $25
2016-03-31 $20
2015-12-31 $28
2015-09-30 $33
2015-06-30 $28
2015-03-31 $12
2014-12-31 $29
2014-09-30 $31
2014-06-30 $31
2014-03-31 $24
2013-12-31 $30
2013-09-30 $23
2013-06-30 $28
2013-03-31 $23
2012-12-31 $22
2012-09-30 $27
2012-06-30 $29
2012-03-31 $27
2011-12-31 $25
2011-09-30 $25
2011-06-30 $29
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.302B $2.040B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
U.S Physical Therapy (USPH) United States $1.157B 29.19
Pennant (PNTG) United States $1.072B 31.31
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00